Enhanced cardiac efficiency with dobutamine after global ischemia.
D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002315:Cardiopulmonary Bypass; D002395:Catecholamines / Q000494:pharmacology*; D003327:Coronary Disease / Q000503:physiopathology*; D004280:Dobutamine / Q000494:pharmacology*; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D009206:Myocardium / Q000032:analysis; D010101:Oxygen Consumption / Q000187:drug effects; D010725:Phosphocreatine / Q000032:analysis; D012079:Renal Circulation / Q000187:drug effects
D002395:Catecholamines; D010725:Phosphocreatine; D004280:Dobutamine; D000255:Adenosine Triphosphate; D004298:Dopamine